First Time in Human, Single Dose and Repeat Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of GSK615915
GSK615915A is being developed as a novel surfactant for use in the formulation of GSK's future generation of Metered Dose Inhalers (MDIs). A surfactant in a MDI would provide a more stable drug suspension, this in turn will produce a consistent dose of drug being delivered with each puff.
100 项与 GSK-615915A 相关的临床结果
100 项与 GSK-615915A 相关的转化医学
100 项与 GSK-615915A 相关的专利(医药)
100 项与 GSK-615915A 相关的药物交易